Abstract:
The present invention relates, inter alia, to compounds having the general formula: in which: Ris a member selected from the group consisting of —OCH, —SCH, —N(CH), —NHCH, —NCH, —NCH, —NCHO, —CHO, —CH(OH)CH, —C(O)CH, —O(CH)N(CH), and —O(CH)NCH; Ris a member selected from the group consisting of hydrogen, halogen, alkyl, acyl, hydroxy, alkoxy (e. g. , methoxy, ethoxy, vinyloxy, ethynyloxy, cyclopropyloxy, etc. ), acyloxy (e. g. , acetoxy, glycinate, etc. ), alkylcarbonate, cypionyloxy, S-alkyl, —SCN, S-acyl and —OC(O)R, wherein Ris a functional group including, but not limited to, alkyl (e. g. , methyl, ethyl, etc. ), alkoxy ester (e. g. , —CHOCH) and alkoxy (—OCH); Ris a member selected from the group consisting of alkyl, hydroxy, alkoxy and acyloxy; Ris a member selected from the group consisting of hydrogen and alkyl; and X is a member selected from the group consisting of ═O and ═N—OR, wherein Ris a member selected from the group consisting of hydrogen and alkyl. In addition to providing the compounds of Formula I, the present invention provides methods wherein the compounds of Formula I are advantageously used, inter alia, to antagonize endogenous progesterone; to induce menses; to treat endometriosis; to treat dysmenorrhea; to treat endocrine hormone-dependent tumors; to treat meningiomas; to treat uterine leiomyomas; to treat uterine fibroids; to inhibit uterine endometrial proliferation; to induce cervical ripening; to induce labor; and for contraception.